Cargando…
A personalized biomedical risk assessment infographic for people who smoke with COPD: a qualitative study
BACKGROUND: Chronic obstructive pulmonary disease (COPD) causes 3 million deaths each year, yet 38% of COPD patients continue to smoke. Despite proof of effectiveness and universal guideline recommendations, smoking cessation interventions are underused in practice. We sought to develop an infograph...
Autores principales: | Gupta, Samir, Panchal, Puru, Sadatsafavi, Mohsen, Ghanouni, Parisa, Sin, Don, Pakhale, Smita, To, Teresa, Zafari, Zafar, Nimmon, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734321/ https://www.ncbi.nlm.nih.gov/pubmed/34991699 http://dx.doi.org/10.1186/s13722-021-00283-1 |
Ejemplares similares
-
The impact of incorporating Bayesian network meta-analysis in cost-effectiveness analysis - a case study of pharmacotherapies for moderate to severe COPD
por: Thorlund, Kristian, et al.
Publicado: (2014) -
The diagnostic performance of patient symptoms in screening for COPD
por: Johnson, Kate M., et al.
Publicado: (2018) -
Cost-effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma in US
por: Zafari, Zafar, et al.
Publicado: (2018) -
Infographic
Publicado: (2022) -
Infographic
Publicado: (2023)